Natural Killer Cell Marker : CD 56, in Visit Clinic

Yes. Human natural killer (NK) cells typically express CD56 (neural cell adhesion molecule) and are identified as CD56+ CD3−. Two main subsets exist: CD56bright NK cells (high cytokine production, lower cytotoxicity) and CD56dim NK cells (greater cytotoxicity, often CD16+). A minority of NK cells can be CD56− in certain disease or chronic infection settings.

CD16 (FcγRIII) on natural killer (NK) cells binds the Fc portion of IgG antibodies, enabling antibody‑dependent cellular cytotoxicity (ADCC). Engagement triggers NK activation, degranulation with perforin/granzymes and secretion of cytokines (e.g., IFN‑γ), leading to targeted killing of antibody‑coated cells. CD16 expression and genetic variants influence IgG affinity and thus NK‑mediated immune responses and therapeutic antibody efficacy.

CD56 is a cell-surface marker (NCAM) whose meaning depends on context. On immune cells it's normal: CD56+ natural killer (NK) subsets (CD56bright/regulatory, CD56dim/cytotoxic) indicate immune function. However, CD56 expression on abnormal cells (e.g., certain leukemias, NK/T‑cell lymphomas, neuroendocrine or plasma cell malignancies) can signal disease and affect prognosis. Thus CD56 positivity is neither inherently good nor bad.

High CD16/CD56 indicates an increased population of natural killer (NK) cells—often cytotoxic or activated NK subsets. This finding can reflect viral infection, acute inflammation, autoimmune conditions, physiologic stress, or, less commonly, NK‑cell proliferation or malignancy. Clinical correlation and follow‑up (repeat flow cytometry, infection workup, and immunology/hematology review) are needed to determine if it’s reactive or pathologic.

CD56 negative means the cells do not express the CD56 (NCAM) surface marker when tested by flow cytometry or immunostaining. Since CD56 is commonly found on natural killer cells and some neural/tumor cells, absence of CD56 affects immunophenotyping, subtype classification, and diagnostic or prognostic interpretation. Clinical significance depends on context and requires correlation with other markers and findings.

CD56 (an NK‑cell marker) is normally expressed on about 5–20% of peripheral blood lymphocytes. In adults the absolute CD56+ (NK) cell count typically ranges roughly 90–600 cells/µL. Subsets include CD56bright (minor population) and CD56dim (majority). Reference ranges can vary by lab, age and methodology, so interpret results with the lab’s specific normal values.